Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation

This publication has 43 references indexed in Scilit:

• The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation
  Thrombosis Research, 2007
• ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
  Circulation, 2006
• Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice
  International Journal Of Clinical Practice, 2006
• Quality of oral anticoagulation in patients with atrial fibrillation: A cross-sectional study in general practice
  The European Journal of General Practice, 2006
• Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population
  Current Medical Research and Opinion, 2005
• Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
  The Lancet, 2003
• Can Warfarin Randomized Trials Be Reproduced in ‘Real Life’?
  Southern Medical Journal, 2000
• Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation
  The American Journal of Cardiology, 1998
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996
• Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
  The Lancet, 1993